EndoArt develops and markets telemetrically driven implantable, batterie-less devices for unmet medical conditions. The company’s main activity is on the treatment of morbid obesity using a remotely controlled gastric band based on its proprietary FloWatch® technology (FloWatch®-TGB, EASYBAND®). Endoart has been acquired in 2007 by Allergan.

Menu